Document is current
Any future updates will be listed below
-
Authors
Odendaal, Christoff
Jager, Emmalie A.
Martines, Anne-Claire M. F.
Vieira-Lara, Marcel A.
Huijkman, Nicolette C. A.
Kiyuna, Ligia A.
Gerding, Albert
Wolters, Justina C.
Heiner-Fokkema, Rebecca
van Eunen, Karen
Derks, Terry G. J.
Bakker, Barbara M. http://orcid.org/0000-0001-6274-3633
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (812616)
Universitair Medisch Centrum Groningen (MD/Ph.D. 18/55)
- License Information
-
More Information
Article History
Received: 14 November 2022
Accepted: 21 June 2023
First Online: 4 September 2023
Declarations
:
: Written informed consent was obtained from patients participating in the urinary acylcarnitine study. The use of historical patient fibroblasts was approved for waived consent (METc 2016/590).
: Not applicable.
: The authors declare that they have no competing interests.
